• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Medisafe Launches Free Med Adherence Grader Tool for Pharma Products

by HITC Staff 10/05/2017 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Medisafe Launches Free Med Adherence Grader Tool for Pharma Products

Medisafe, a Boston, MA-based medication adherence platform has announced the launch of Adherence Grader, a free data insights tool for the healthcare community interested in tracking medication adherence.

Now available at AdherenceGrader.com, the tool gives pharmaceutical brands, researchers, caregivers, journalists and other interested parties across the healthcare continuum instant access to how well Medisafe users adhere to alternative medication regimens on a relative basis.

Adherence Grader instantly reports the adherence scores of thousands of medications patients manage and take through the help Medisafe’s award-winning application. These scores are indexed using a proprietary algorithm of self-reported adherence, persistence and other factors derived from the historical performance of patients using Medisafe as an intervention solution.

For a more detailed patient cohort-level view of adherence, Medisafe recently launched Medisafe Insights, which uses a combination of data analytics and qualitative survey tools to demystify patient adherence obstacles and shed light on health engagement patterns. Medisafe knows if and when patients take each medication dose, so it is able to report on hourly and daily trends, reasons behind missed doses, and other important trends. This information can enhance data available from traditional sources of medication adherence, which typically draw only on data from monthly refill records or focus groups.

 

The causes of non-adherence vary dramatically by medication, condition, patient and specific timeframe across the patient journey, negatively impacting patient quality of care and health outcomes. Non-adherence results in higher emergency and mortality rates and is estimated to cost the US healthcare system alone in excess of $290 billion a year.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Medication Adherence, Medisafe, Pharma

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |